Akero Therapeutics Inc (NASDAQ:AKRO)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - AKRO

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - AKRO

  • Market Cap$895.280m
  • SymbolNASDAQ:AKRO
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS00973Y1082

Company Profile

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical need. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate AKR-001 is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

Latest AKRO news

Currently there for this company. Visit our news hub for other news .